메뉴 건너뛰기




Volumn 27, Issue 8, 2012, Pages 3063-3071

The consequences of chronic kidney disease on bone metabolism and growth in children

Author keywords

bone; chronic kidney disease; growth; paediatrics; vascular calcifications

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCITRIOL; CALCIUM SALT; CINACALCET; DOXERCALCIFEROL; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; LANTHANUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PLACEBO; RECOMBINANT GROWTH HORMONE; SEVELAMER; STEROL DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D STEROL;

EID: 84864624787     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs299     Document Type: Article
Times cited : (80)

References (102)
  • 1
    • 34848924291 scopus 로고    scopus 로고
    • A structural approach to the assessment of fracture risk in children and adolescents with chronic kidney disease
    • Leonard MB. A structural approach to the assessment of fracture risk in children and adolescents with chronic kidney disease. Pediatr Nephrol 2007; 22: 1815-1824.
    • (2007) Pediatr Nephrol , vol.22 , pp. 1815-1824
    • Leonard, M.B.1
  • 2
    • 33846021310 scopus 로고    scopus 로고
    • Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression
    • Cunningham J. Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression. J Am Soc Nephrol 2007; 18: 223-234.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 223-234
    • Cunningham, J.1
  • 3
    • 38349016751 scopus 로고    scopus 로고
    • Chronic kidney disease mineral and bone disorder in children
    • Wesseling K, Bakkaloglu S, Salusky I. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol 2008; 23: 195-207.
    • (2008) Pediatr Nephrol , vol.23 , pp. 195-207
    • Wesseling, K.1    Bakkaloglu, S.2    Salusky, I.3
  • 4
    • 77951253893 scopus 로고    scopus 로고
    • Cardiovascular risk in chronic kidney disease (CKD): The CKD-mineral bone disorder (CKD- MBD)
    • Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review
    • Hruska KA, Choi ET, Memon I et al. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD- MBD). Pediatr Nephrol [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review]. 2010; 25: 769-778.
    • (2010) Pediatr Nephrol , vol.25 , pp. 769-778
    • Hruska, K.A.1    Choi, E.T.2    Memon, I.3
  • 5
    • 6444244425 scopus 로고    scopus 로고
    • Severe bone disease and low bone mineral density after juvenile renal failure
    • Groothoff JW, Offringa M, Van Eck-Smit BL et al. Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int 2003; 63: 266-275.
    • (2003) Kidney Int , vol.63 , pp. 266-275
    • Groothoff, J.W.1    Offringa, M.2    Van Eck-Smit, B.L.3
  • 6
    • 0034682247 scopus 로고    scopus 로고
    • Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
    • Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
    • (2000) N Engl J Med , vol.342 , pp. 1478-1483
    • Goodman, W.G.1    Goldin, J.2    Kuizon, B.D.3
  • 7
    • 0037008747 scopus 로고    scopus 로고
    • Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway
    • Yamashita T, Konishi M, Miyake A et al. Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem 2002; 277: 28265-28270.
    • (2002) J Biol Chem , vol.277 , pp. 28265-28270
    • Yamashita, T.1    Konishi, M.2    Miyake, A.3
  • 8
    • 37049036873 scopus 로고    scopus 로고
    • Growth hormone axis in chronic kidney disease
    • Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol 2008; 23: 41-48.
    • (2008) Pediatr Nephrol , vol.23 , pp. 41-48
    • Mahesh, S.1    Kaskel, F.2
  • 9
    • 0029080531 scopus 로고
    • Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy
    • Salusky IB, Goodman WG. Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy. Kidney Int 1995; 48: 657-665.
    • (1995) Kidney Int , vol.48 , pp. 657-665
    • Salusky, I.B.1    Goodman, W.G.2
  • 10
    • 41749089487 scopus 로고    scopus 로고
    • Pituitary hormones and their control by the hypothalamus
    • Guyton A (ed)., 11th edn. Philadelphia: Elsevier Saunders
    • Guyton A, Hall J. Pituitary hormones and their control by the hypothalamus. In: Guyton A (ed). Textbook of Medical Physiology, 11th edn. Philadelphia: Elsevier Saunders, 2006, pp. 918-929.
    • (2006) Textbook of Medical Physiology , pp. 918-929
    • Guyton, A.1    Hall, J.2
  • 11
    • 79953033748 scopus 로고    scopus 로고
    • Growth hormone mediates pubertal skeletal development independent of hepatic IGF-1 production
    • Research Support, N.I.H., Extramural
    • Courtland HW, Sun H, Beth-On M et al. Growth hormone mediates pubertal skeletal development independent of hepatic IGF-1 production. J Bone Miner Res [Research Support, N.I.H., Extramural] 2011; 26: 761-768.
    • (2011) J Bone Miner Res , vol.26 , pp. 761-768
    • Courtland, H.W.1    Sun, H.2    Beth-On, M.3
  • 12
    • 0032848690 scopus 로고    scopus 로고
    • Growth retardation in children with chronic renal failure
    • Kuizon BD, Salusky IB. Growth retardation in children with chronic renal failure. J Bone Miner Res 1999; 14: 1680-1690.
    • (1999) J Bone Miner Res , vol.14 , pp. 1680-1690
    • Kuizon, B.D.1    Salusky, I.B.2
  • 13
    • 84857069906 scopus 로고    scopus 로고
    • Early skeletal and biochemical alterations in pediatric chronic kidney disease
    • Wesseling-Perry K, Pereira RC, Tseng CH et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2012; 7: 146-152.
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 146-152
    • Wesseling-Perry, K.1    Pereira, R.C.2    Tseng, C.H.3
  • 14
    • 36849017126 scopus 로고    scopus 로고
    • The parathyroid is a target organ for FGF23 in rats
    • Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007; 117: 4003-4008.
    • (2007) J Clin Invest , vol.117 , pp. 4003-4008
    • Ben-Dov, I.Z.1    Galitzer, H.2    Lavi-Moshayoff, V.3
  • 15
    • 58549086350 scopus 로고    scopus 로고
    • The bone-renal axis in early chronic kidney disease: An emerging paradigm
    • Danziger J. The bone-renal axis in early chronic kidney disease: an emerging paradigm. Nephrol Dial Transplant 2008; 23: 2733-2737.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 2733-2737
    • Danziger, J.1
  • 16
    • 79957870135 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
    • Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int [Research Support, N.I.H., Extramural] 2011; 79: 1370-1378.
    • (2011) Kidney Int [Research Support, N.I.H., Extramural] , vol.79 , pp. 1370-1378
    • Isakova, T.1    Wahl, P.2    Vargas, G.S.3
  • 17
    • 76149101238 scopus 로고    scopus 로고
    • Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active
    • Shimada T, Urakawa I, Isakova T et al. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 2010; 95: 578-585.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 578-585
    • Shimada, T.1    Urakawa, I.2    Isakova, T.3
  • 18
    • 65649129465 scopus 로고    scopus 로고
    • FGF23-mediated regulation of systemic phosphate homeostasis: Is Klotho an essential player?
    • Razzaque MS. FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol 2009; 296: F470-F476.
    • (2009) Am J Physiol Renal Physiol , vol.296
    • Razzaque, M.S.1
  • 19
  • 20
    • 76749134283 scopus 로고    scopus 로고
    • Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
    • Lafage-Proust MH. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients? Kidney Int 2010; 77: 390-392.
    • (2010) Kidney Int , vol.77 , pp. 390-392
    • Lafage-Proust, M.H.1
  • 21
    • 74449086740 scopus 로고    scopus 로고
    • Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients
    • Komaba H, Goto S, Fujii H et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010; 77: 232-238.
    • (2010) Kidney Int , vol.77 , pp. 232-238
    • Komaba, H.1    Goto, S.2    Fujii, H.3
  • 22
    • 74449094013 scopus 로고    scopus 로고
    • Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease
    • Galitzer H, Ben-Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010; 77:211-218.
    • (2010) Kidney Int , vol.77 , pp. 11-218
    • Galitzer, H.1    Ben-Dov, I.Z.2    Silver, J.3
  • 23
    • 0030892773 scopus 로고    scopus 로고
    • The calcium-parathyroid hormone regulation in chronic renal failure investigation of its dynamic secretion pattern
    • Heidbreder E, Naujoks H, Brosa U et al. The calcium-parathyroid hormone regulation in chronic renal failure investigation of its dynamic secretion pattern. Horm Metab Res 1997; 29: 70-75.
    • (1997) Horm Metab Res , vol.29 , pp. 70-75
    • Heidbreder, E.1    Naujoks, H.2    Brosa, U.3
  • 24
    • 33645224419 scopus 로고    scopus 로고
    • Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
    • Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
    • (2006) Science , vol.311 , pp. 1770-1773
    • Liu, P.T.1    Stenger, S.2    Li, H.3
  • 25
    • 77953443605 scopus 로고    scopus 로고
    • Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients
    • Priemel M, von Domarus C, Klatte TO et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2009; 25: 305-312.
    • (2009) J Bone Miner Res , vol.25 , pp. 305-312
    • Priemel, M.1    Von Domarus, C.2    Klatte, T.O.3
  • 26
    • 79953715634 scopus 로고    scopus 로고
    • Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor
    • Ritter CS, Brown AJ. Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor. J Mol Endocrinol [In Vitro Research Support, Non-U.S. Gov't] 2011; 46: 63-66.
    • (2011) J Mol Endocrinol [In Vitro Research Support, Non-U.S. Gov't] , vol.46 , pp. 63-66
    • Ritter, C.S.1    Brown, A.J.2
  • 27
    • 84857188798 scopus 로고    scopus 로고
    • Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: A randomized trial
    • doi:10.2215/CJN.04760511
    • Shroff R, Wan M, Gullet A et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 2012:doi:10.2215/CJN.04760511.
    • (2012) Clin J Am Soc Nephrol
    • Shroff, R.1    Wan, M.2    Gullet, A.3
  • 28
    • 78649908321 scopus 로고    scopus 로고
    • Vitamin D revisited: A cornerstone of health?
    • Bacchetta J, Ranchin B, Dubourg L et al. Vitamin D revisited: a cornerstone of health? Arch Pediatr 2010; 17: 1687-1695.
    • (2010) Arch Pediatr , vol.17 , pp. 1687-1695
    • Bacchetta, J.1    Ranchin, B.2    Dubourg, L.3
  • 29
    • 84872829145 scopus 로고    scopus 로고
    • NAPRTCS. Annual report, section dialysis 12-12005
    • NAPRTCS. Annual report, section dialysis 12-12005.
  • 31
    • 77951254829 scopus 로고    scopus 로고
    • First-year response to rhGH therapy in children with CKD: A National Cooperative Growth Study Report
    • Mahan JD, Warady BA, Frane J et al. First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report. Pediatr Nephrol 2010; 25: 1125-1130.
    • (2010) Pediatr Nephrol , vol.25 , pp. 1125-1130
    • Mahan, J.D.1    Warady, B.A.2    Frane, J.3
  • 33
    • 33745107468 scopus 로고    scopus 로고
    • Assessment and treatment of short stature in pediatric patients with chronic kidney disease: A consensus statement
    • Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 2006; 21: 917-930.
    • (2006) Pediatr Nephrol , vol.21 , pp. 917-930
    • Mahan, J.D.1    Warady, B.A.2
  • 34
    • 30944444013 scopus 로고    scopus 로고
    • Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines
    • Klaus G, Watson A, Edefonti A et al. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 2006; 21: 151-159.
    • (2006) Pediatr Nephrol , vol.21 , pp. 151-159
    • Klaus, G.1    Watson, A.2    Edefonti, A.3
  • 35
    • 0030972033 scopus 로고    scopus 로고
    • Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: Correlation with GH insensitivity
    • The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure
    • Tonshoff B, Cronin MJ, Reichert M et al. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. J Clin Endocrinol Metab 1997; 82: 1007-1013.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 1007-1013
    • Tonshoff, B.1    Cronin, M.J.2    Reichert, M.3
  • 36
    • 0000769033 scopus 로고    scopus 로고
    • Derangements of the somatotropic hormone axis in chronic renal failure
    • Tonshoff B, Blum WF, Mehls O. Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int Suppl 1997; 58: S106-S113.
    • (1997) Kidney Int Suppl , vol.58
    • Tonshoff, B.1    Blum, W.F.2    Mehls, O.3
  • 37
    • 9844239917 scopus 로고    scopus 로고
    • Insulin-like growth factorbinding protein-6 levels are elevated in serum of children with chronic renal failure
    • a report of the Southwest Pediatric Nephrology Study Group
    • Powell DR, Liu F, Baker BK et al. Insulin-like growth factorbinding protein-6 levels are elevated in serum of children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. J Clin Endocrinol Metab 1997; 82: 2978-2984.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 2978-2984
    • Powell, D.R.1    Liu, F.2    Baker, B.K.3
  • 38
    • 7844235112 scopus 로고    scopus 로고
    • The insulin-like growth factor axis and growth in children with chronic renal failure
    • a report of the Southwest Pediatric Nephrology Study Group
    • Powell DR, Durham SK, Liu F et al. The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. J Clin Endocrinol Metab 1998; 83: 1654-1661.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 1654-1661
    • Powell, D.R.1    Durham, S.K.2    Liu, F.3
  • 39
    • 58049154592 scopus 로고    scopus 로고
    • Bone imaging and chronic kidney disease: Will high-resolution peripheral tomography improve bone evaluation and therapeutic management?
    • Bacchetta J, Boutroy S, Juillard L et al. Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management? J Ren Nutr 2009; 19: 44-49.
    • (2009) J Ren Nutr , vol.19 , pp. 44-49
    • Bacchetta, J.1    Boutroy, S.2    Juillard, L.3
  • 40
    • 47549099246 scopus 로고    scopus 로고
    • Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: Independence from renal dysfunction
    • Yamada S, Inaba M, Kurajoh M et al. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol (Oxf) 2008; 69: 189-196.
    • (2008) Clin Endocrinol (Oxf) , vol.69 , pp. 189-196
    • Yamada, S.1    Inaba, M.2    Kurajoh, M.3
  • 41
    • 33745203732 scopus 로고    scopus 로고
    • Pediatric reference intervals for bone markers
    • Yang L, Grey V. Pediatric reference intervals for bone markers. Clin Biochem 2006; 39: 561-568.
    • (2006) Clin Biochem , vol.39 , pp. 561-568
    • Yang, L.1    Grey, V.2
  • 42
    • 76749152242 scopus 로고    scopus 로고
    • Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents
    • Bianchi ML, Baim S, Bishop NJ et al. Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol 2010; 25: 37-47.
    • (2010) Pediatr Nephrol , vol.25 , pp. 37-47
    • Bianchi, M.L.1    Baim, S.2    Bishop, N.J.3
  • 43
    • 76749111156 scopus 로고    scopus 로고
    • Limitations of dual x-ray absorptiometry in children with chronic kidney disease
    • Weber LT, Mehls O. Limitations of dual x-ray absorptiometry in children with chronic kidney disease. Pediatr Nephrol 2010; 25: 3-5.
    • (2010) Pediatr Nephrol , vol.25 , pp. 3-5
    • Weber, L.T.1    Mehls, O.2
  • 44
    • 0034527548 scopus 로고    scopus 로고
    • Clinical review 117: Hormonal determinants and disorders of peak bone mass in children
    • Soyka LA, Fairfield WP, Klibanski A. Clinical review 117: hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab 2000; 85: 3951-3963.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 3951-3963
    • Soyka, L.A.1    Fairfield, W.P.2    Klibanski, A.3
  • 46
    • 58149400642 scopus 로고    scopus 로고
    • The role of bone biopsy in patients with chronic renal failure
    • Miller PD. The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol 2008; 3 (Suppl 3): S140-S150.
    • (2008) Clin J Am Soc Nephrol , vol.3 , Issue.SUPPL. 3
    • Miller, P.D.1
  • 47
    • 84857069906 scopus 로고    scopus 로고
    • Early skeletal and biochemical alterations in pediatric chronic kidney disease
    • Wesseling-Perry K, Pereira RC, Tseng CH et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2012; 7: 146-152.
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 146-152
    • Wesseling-Perry, K.1    Pereira, R.C.2    Tseng, C.H.3
  • 48
    • 0023820468 scopus 로고
    • Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD
    • Salusky IB, Coburn JW, Brill J et al. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 1988; 33: 975-982.
    • (1988) Kidney Int , vol.33 , pp. 975-982
    • Salusky, I.B.1    Coburn, J.W.2    Brill, J.3
  • 49
    • 0028035183 scopus 로고
    • Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
    • Goodman WG, Ramirez JA, Belin TR et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 1994; 46: 1160-1166.
    • (1994) Kidney Int , vol.46 , pp. 1160-1166
    • Goodman, W.G.1    Ramirez, J.A.2    Belin, T.R.3
  • 50
    • 0023488581 scopus 로고
    • Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee
    • Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987; 2: 595-610.
    • (1987) J Bone Miner Res , vol.2 , pp. 595-610
    • Parfitt, A.M.1    Drezner, M.K.2    Glorieux, F.H.3
  • 51
    • 33645757920 scopus 로고    scopus 로고
    • Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    • Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953.
    • (2006) Kidney Int , vol.69 , pp. 1945-1953
    • Moe, S.1    Drueke, T.2    Cunningham, J.3
  • 52
    • 77958590277 scopus 로고    scopus 로고
    • Values of the new bone classification system in pediatric renal osteodystrophy
    • Epub, doi;10.2215/CJN.01330210
    • Bakkaloglu S, Wesseling-Perry K, Pereira R et al. Values of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol 2010: Epub, doi;10.2215/CJN.01330210.
    • (2010) Clin J Am Soc Nephrol
    • Bakkaloglu, S.1    Wesseling-Perry, K.2    Pereira, R.3
  • 53
    • 0031888062 scopus 로고    scopus 로고
    • Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD
    • Kuizon BD, Goodman WG, Juppner H et al. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 1998; 53: 205-211.
    • (1998) Kidney Int , vol.53 , pp. 205-211
    • Kuizon, B.D.1    Goodman, W.G.2    Juppner, H.3
  • 55
    • 77953383192 scopus 로고    scopus 로고
    • Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease
    • Bacchetta J, Boutroy S, Vilayphiou N et al. Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res 2010; 25: 849-857.
    • (2010) J Bone Miner Res , vol.25 , pp. 849-857
    • Bacchetta, J.1    Boutroy, S.2    Vilayphiou, N.3
  • 56
    • 27944449749 scopus 로고    scopus 로고
    • In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography
    • Boutroy S, Bouxsein ML, Munoz F et al. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 2005; 90: 6508-6515.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 6508-6515
    • Boutroy, S.1    Bouxsein, M.L.2    Munoz, F.3
  • 57
    • 33847106358 scopus 로고    scopus 로고
    • Bone texture analysis on direct digital radiographic images: Precision study and relationship with bone mineral density at the os calcis
    • Lespessailles E, Gadois C, Lemineur G et al. Bone texture analysis on direct digital radiographic images: precision study and relationship with bone mineral density at the os calcis. Calcif Tissue Int 2007; 80: 97-102.
    • (2007) Calcif Tissue Int , vol.80 , pp. 97-102
    • Lespessailles, E.1    Gadois, C.2    Lemineur, G.3
  • 58
    • 37549071099 scopus 로고    scopus 로고
    • Magnetic resonance imaging for osteoporosis
    • Majumdar S. Magnetic resonance imaging for osteoporosis. Skeletal Radiol 2008; 37: 95-97.
    • (2008) Skeletal Radiol , vol.37 , pp. 95-97
    • Majumdar, S.1
  • 59
    • 33746454833 scopus 로고    scopus 로고
    • Measuring bone mass in children: Can we really do it?
    • Bachrach LK. Measuring bone mass in children: can we really do it? Horm Res 2006; 65 (Suppl 2): 11-16.
    • (2006) Horm Res , vol.65 , Issue.SUPPL. 2 , pp. 11-16
    • Bachrach, L.K.1
  • 60
    • 77951253045 scopus 로고    scopus 로고
    • Bone metabolism in oxalosis: A single-center study using new bone imaging techniques and biomarkers
    • doi 10.1007/s00467-010- 1453x
    • Bacchetta J, Fargue S, Boutroy S et al. Bone metabolism in oxalosis: a single-center study using new bone imaging techniques and biomarkers. Pediatr Nephrol 2010:doi 10.1007/s00467-010- 1453x.
    • (2010) Pediatr Nephrol
    • Bacchetta, J.1    Fargue, S.2    Boutroy, S.3
  • 61
    • 0038498057 scopus 로고    scopus 로고
    • Bone density measurements in pediatric patients with renal osteodystrophy
    • Lima EM, Goodman WG, Kuizon BD et al. Bone density measurements in pediatric patients with renal osteodystrophy. Pediatr Nephrol 2003; 18: 554-559.
    • (2003) Pediatr Nephrol , vol.18 , pp. 554-559
    • Lima, E.M.1    Goodman, W.G.2    Kuizon, B.D.3
  • 63
    • 84859839243 scopus 로고    scopus 로고
    • Bone density and cortical structure after pediatric renal transplantation
    • Terpstra AM, Kalkwarf HJ, Shults J et al. Bone density and cortical structure after pediatric renal transplantation. J Am Soc Nephrol 2012.
    • (2012) J Am Soc Nephrol
    • Terpstra, A.M.1    Kalkwarf, H.J.2    Shults, J.3
  • 64
    • 79954440825 scopus 로고    scopus 로고
    • Bone assessment in children with chronic kidney disease: Data from two new bone imaging techniques in a single-center pilot study
    • Bacchetta J, Boutroy S, Vilayphiou N et al. Bone assessment in children with chronic kidney disease: data from two new bone imaging techniques in a single-center pilot study. Pediatr Nephrol [Research Support, Non-U.S. Gov't]. 2011; 26: 587-595.
    • (2011) Pediatr Nephrol [Research Support, Non-U.S. Gov't] , vol.26 , pp. 587-595
    • Bacchetta, J.1    Boutroy, S.2    Vilayphiou, N.3
  • 65
    • 68949114585 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
    • KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 113: S1-S130.
    • (2009) Kidney Int Suppl , vol.113
  • 66
    • 23044472551 scopus 로고    scopus 로고
    • Parathyroid hormone and growth in children with chronic renal failure
    • Waller SC, Ridout D, Cantor T et al. Parathyroid hormone and growth in children with chronic renal failure. Kidney Int 2005; 67: 2338-2345.
    • (2005) Kidney Int , vol.67 , pp. 2338-2345
    • Waller, S.C.1    Ridout, D.2    Cantor, T.3
  • 68
    • 80255139971 scopus 로고    scopus 로고
    • Mineral and bone disorders in children with chronic kidney disease
    • Schmitt CP, Mehls O. Mineral and bone disorders in children with chronic kidney disease. Nat Rev Nephrol 2011; 7: 624-634.
    • (2011) Nat Rev Nephrol , vol.7 , pp. 624-634
    • Schmitt, C.P.1    Mehls, O.2
  • 69
    • 38349011549 scopus 로고    scopus 로고
    • What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; What is the evidence?
    • Rees L. What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 2008; 23: 179-184.
    • (2008) Pediatr Nephrol , vol.23 , pp. 179-184
    • Rees, L.1
  • 72
    • 34447310263 scopus 로고    scopus 로고
    • Growth and PTH in prepubertal children on long-term dialysis
    • Cansick J, Waller S, Ridout D et al. Growth and PTH in prepubertal children on long-term dialysis. Pediatr Nephrol 2007; 22: 1349-1354.
    • (2007) Pediatr Nephrol , vol.22 , pp. 1349-1354
    • Cansick, J.1    Waller, S.2    Ridout, D.3
  • 74
    • 25844515848 scopus 로고    scopus 로고
    • Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols
    • Salusky IB, Goodman WG, Sahney S et al. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol 2005; 16: 2501-2508.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2501-2508
    • Salusky, I.B.1    Goodman, W.G.2    Sahney, S.3
  • 75
    • 33645218040 scopus 로고    scopus 로고
    • A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD
    • Pieper AK, Haffner D, Hoppe B et al. A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 2006; 47: 625-635.
    • (2006) Am J Kidney Dis , vol.47 , pp. 625-635
    • Pieper, A.K.1    Haffner, D.2    Hoppe, B.3
  • 76
    • 77950474312 scopus 로고    scopus 로고
    • Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
    • Gonzalez E, Schomberg J, Amin N et al. Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients. Pediatr Nephrol 2010; 25: 373-375.
    • (2010) Pediatr Nephrol , vol.25 , pp. 373-375
    • Gonzalez, E.1    Schomberg, J.2    Amin, N.3
  • 79
    • 77951626687 scopus 로고    scopus 로고
    • Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations
    • Imel EA, DiMeglio LA, Hui SL et al. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab [Clinical Trial Research Support, N.I.H., Extramural] 2010; 95: 1846-1850.
    • (2010) J Clin Endocrinol Metab [Clinical Trial Research Support, N.I.H., Extramural] , vol.95 , pp. 1846-1850
    • Imel, E.A.1    Dimeglio, L.A.2    Hui, S.L.3
  • 80
    • 40449141435 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation
    • Serra AL, Braun SC, Starke A et al. Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation. Am J Transplant [Research Support, Non-U.S. Gov't] 2008; 8: 803-810.
    • (2008) Am J Transplant [Research Support, Non-U.S. Gov't] , vol.8 , pp. 803-810
    • Serra, A.L.1    Braun, S.C.2    Starke, A.3
  • 82
    • 51549087339 scopus 로고    scopus 로고
    • Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease
    • Muscheites J, Wigger M, Drueckler E et al. Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol 2008; 23: 1823-1829.
    • (2008) Pediatr Nephrol , vol.23 , pp. 1823-1829
    • Muscheites, J.1    Wigger, M.2    Drueckler, E.3
  • 83
    • 67651095865 scopus 로고    scopus 로고
    • Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism
    • Bacchetta J, Plotton I, Ranchin B et al. Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism. Nephrol Dialysis, Transplant 2009; 24: 2595-2598.
    • (2009) Nephrol Dialysis, Transplant , vol.24 , pp. 2595-2598
    • Bacchetta, J.1    Plotton, I.2    Ranchin, B.3
  • 84
    • 0028204116 scopus 로고
    • Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebocontrolled study. Genentech Cooperative Study Group
    • Fine RN, Kohaut EC, Brown D et al. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebocontrolled study. Genentech Cooperative Study Group. J Pediatr 1994; 124: 374-382.
    • (1994) J Pediatr , vol.124 , pp. 374-382
    • Fine, R.N.1    Kohaut, E.C.2    Brown, D.3
  • 85
    • 0025734231 scopus 로고
    • Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure
    • Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM et al. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 1991; 338: 585-590.
    • (1991) Lancet , vol.338 , pp. 585-590
    • Hokken-Koelega, A.C.1    Stijnen, T.2    De Muinck Keizer-Schrama, S.M.3
  • 86
    • 0034727051 scopus 로고    scopus 로고
    • Effect of growth hormone treatment on the adult height of children with chronic renal failure. German study group for growth hormone treatment in chronic renal failure
    • Haffner D, Schaefer F, Nissel R et al. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German study group for growth hormone treatment in chronic renal failure. N Engl J Med 2000; 343: 923-930.
    • (2000) N Engl J Med , vol.343 , pp. 923-930
    • Haffner, D.1    Schaefer, F.2    Nissel, R.3
  • 87
    • 25844525840 scopus 로고    scopus 로고
    • K/DOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease
    • K/DOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005; 46 (Suppl 1): 1-122.
    • (2005) Sm Am J Kidney Dis , vol.46 , Issue.SUPPL. 1 , pp. 1-122
  • 88
    • 77951259042 scopus 로고    scopus 로고
    • Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: A historical perspective
    • Fine RN. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol 2010; 25: 725-732.
    • (2010) Pediatr Nephrol , vol.25 , pp. 725-732
    • Fine, R.N.1
  • 89
    • 0015949845 scopus 로고
    • Morphological studies on pathogenesis of epiphyseal slipping in uremic children
    • Krempien B, Mehls O, Ritz E. Morphological studies on pathogenesis of epiphyseal slipping in uremic children. Virchows Arch A Pathol Anat Histol 1974; 362: 129-143.
    • (1974) Virchows Arch A Pathol Anat Histol , vol.362 , pp. 129-143
    • Krempien, B.1    Mehls, O.2    Ritz, E.3
  • 90
    • 34548389392 scopus 로고    scopus 로고
    • Use of rhGH in children with chronic kidney disease: Lessons from NAPRTCS
    • Seikaly MG, Salhab N, Warady BA et al. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatr Nephrol 2007; 22: 1195-1204.
    • (2007) Pediatr Nephrol , vol.22 , pp. 1195-1204
    • Seikaly, M.G.1    Salhab, N.2    Warady, B.A.3
  • 91
    • 53749100950 scopus 로고    scopus 로고
    • Long-term results of rhGH treatment in children with renal failure: Experience of the French Society of Pediatric Nephrology
    • Berard E, Andre JL, Guest G et al. Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology. Pediatr Nephrol 2008; 23: 2031-2038.
    • (2008) Pediatr Nephrol , vol.23 , pp. 2031-2038
    • Berard, E.1    Andre, J.L.2    Guest, G.3
  • 93
    • 0028968673 scopus 로고
    • Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids
    • Sanchez CP, Goodman WG, Brandli D et al. Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids. J Bone Miner Res 1995; 10: 2-6.
    • (1995) J Bone Miner Res , vol.10 , pp. 2-6
    • Sanchez, C.P.1    Goodman, W.G.2    Brandli, D.3
  • 94
    • 0142095035 scopus 로고    scopus 로고
    • Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency
    • Baroncelli GI, Bertelloni S, Sodini F et al. Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency. J Pediatr Endocrinol Metab 2003; 16 (Suppl 2): 327-335.
    • (2003) J Pediatr Endocrinol Metab , vol.16 , Issue.SUPPL. 2 , pp. 327-335
    • Baroncelli, G.I.1    Bertelloni, S.2    Sodini, F.3
  • 95
    • 1942440983 scopus 로고    scopus 로고
    • Adults with partial growth hormone deficiency have an adverse body composition
    • Murray RD, Adams JE, Shalet SM. Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 2004; 89: 1586-1591.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 1586-1591
    • Murray, R.D.1    Adams, J.E.2    Shalet, S.M.3
  • 96
    • 0033305698 scopus 로고    scopus 로고
    • Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism
    • Colao A, Di Somma C, Pivonello R et al. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999; 84: 1919-1924.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 1919-1924
    • Colao, A.1    Di Somma, C.2    Pivonello, R.3
  • 97
    • 0030319373 scopus 로고    scopus 로고
    • Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial
    • Baum HB, Biller BM, Finkelstein JS et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 883-890.
    • (1996) Ann Intern Med , vol.125 , pp. 883-890
    • Baum, H.B.1    Biller, B.M.2    Finkelstein, J.S.3
  • 99
    • 47749122148 scopus 로고    scopus 로고
    • Obstacles to the prescribing of growth hormone in children with chronic kidney disease
    • Greenbaum LA, Hidalgo G, Chand D et al. Obstacles to the prescribing of growth hormone in children with chronic kidney disease. Pediatr Nephrol 2008; 23: 1531-1535.
    • (2008) Pediatr Nephrol , vol.23 , pp. 1531-1535
    • Greenbaum, L.A.1    Hidalgo, G.2    Chand, D.3
  • 100
    • 61949280086 scopus 로고    scopus 로고
    • KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary
    • KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis [Practice Guideline] 2009; 53 (3 Suppl 2): S11-S104.
    • (2009) Am J Kidney Dis [Practice Guideline] , vol.53 , Issue.3 SUPPL. 2
  • 101
    • 0036247539 scopus 로고    scopus 로고
    • Adverse clinical outcomes associated with short stature at dialysis initiation: A report of the North American Pediatric Renal Transplant Cooperative Study
    • Furth SL, Stablein D, Fine RN et al. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2002; 109: 909-913.
    • (2002) Pediatrics , vol.109 , pp. 909-913
    • Furth, S.L.1    Stablein, D.2    Fine, R.N.3
  • 102
    • 62349131324 scopus 로고    scopus 로고
    • Serum fibroblast growth factor-23 levels in chronic haemodialysis patients
    • Ibrahim S, Rashed L. Serum fibroblast growth factor-23 levels in chronic haemodialysis patients. Int Urol Nephrol 2009; 41: 163-169
    • (2009) Int Urol Nephrol , vol.41 , pp. 163-169
    • Ibrahim, S.1    Rashed, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.